FRS2 anticorps (AA 275-303)

N° du produit ABIN1538225

L’anticorps Lapin Polyclonal anti-FRS2 a été validé pour WB. Il convient pour détecter FRS2 dans des échantillons de Humain.

Aperçu rapide pour FRS2 anticorps (AA 275-303) (ABIN1538225)

Antigène: FRS2 (Fibroblast Growth Factor Receptor Substrate 2 (FRS2))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp FRS2 est non-conjugé

Application: Western Blotting (WB)

Clone: RB39481

Détail du produit anti-FRS2 anticorps

Épitope: AA 275-303

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This FRS2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 275-303 amino acids from the Central region of human FRS2.

Isotype: Ig Fraction

Information d'application

Indications d'application: WB: 1:1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: FRS2 Antibody (Center) can be refrigerated at 2-8 °C for up to 6 months. For long term storage, keep at -20 °C.

Date de péremption: 6 months

Détails sur FRS2

Antigène: FRS2 (Fibroblast Growth Factor Receptor Substrate 2 (FRS2))

Autre désignation: FRS2

Sujet: Adapter protein that links FGR and NGF receptors to downstream signaling pathways. Involved in the activation of MAP kinases. Modulates signaling via SHC1 by competing for a common binding site on NTRK1.

Poids moléculaire: 57029

ID gène: 10818

NCBI Accession: NP_001036020, NP_001265280, NP_001265282, NP_001265283, NP_001265284, NP_001265285, NP_001265286, NP_006645

UniProt: Q8WU20

Pathways: Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Signaling Events mediated by VEGFR1 and VEGFR2